Sofinnova Crossover I - 12 Jan 2026 SCHEDULE 13D/A Report for Abivax S.A. Ordinary Shares, par value EUR0.01 per share (ABVX)

Filing Manager
Sofinnova Crossover I
Reporting Manager
Sofinnova Crossover I SLP
Security
Abivax S.A. Ordinary Shares, par value EUR0.01 per share
Symbol
ABVX
Shares outstanding
83,110,104 shares
Disclosed Ownership
6,399,478 shares
Ownership
7.7%
Form type
SCHEDULE 13D/A
Filing time
14 Jan 2026, 16:13:22 UTC
Date of event
12 Jan 2026
Previous filing
30 Oct 2025
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Sofinnova Crossover I SLP 7.7% 6,399,478 6,399,478 0 /s/ Antoine Papiernik Managing Partner 0001845105
Sofinnova Partners SAS 7.7% 6,399,478 6,399,478 0 /s/ Antoine Papiernik Managing Partner 0001574139
Antoine Papiernik 7.7% 6,399,478 6,399,478 0 /s/ Antoine Papiernik Antoine Papiernik
Cedric Moreau 7.7% 6,399,478 6,399,478 0 /s/ Cedric Moreau Cedric Moreau
Kinam Hong 7.7% 6,399,478 6,399,478 0 /s/ Kinam Hong Kinam Hong
Joseph Anderson 7.7% 6,399,478 6,399,478 0 /s/ Joseph Anderson Joseph Anderson
Jacques Theurillat 7.7% 6,399,478 6,399,478 0 /s/ Jacques Theurillat Jacques Theurillat